SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing explosive price volatility driven by a massive short squeeze and concerns over extreme institutional concentration, fueling a heated debate between retail traders expecting a push toward quadruple digits and skeptics warning of a inevitable collapse. Investors are closely monitoring the stock's parabolic climb for signs of an impending secondary offering or regulatory intervention, as the community remains deeply divided over the sustainability of a rental car company trading at these valuations.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following a successful FCC grant of full commercial authority to deploy 223 additional satellites, a major milestone that clears critical regulatory hurdles for its U.S. direct-to-cell service expansion. Community sentiment is highly polarized, with retail investors discussing the potential for a massive short squeeze and long-term upside, while some bears express skepticism regarding launch timelines and operational risks despite the regulatory win.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing extreme volatility driven by President Trump's repeated, last-minute after-hours announcements regarding ceasefire extensions with Iran, which the community has labeled as "Taco Tuesdays." Traders are actively debating whether these tactical delays and ongoing naval blockades signal a strategic de-escalation or a sign of weakness that leaves global energy markets vulnerable to further disruption.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intensified market volatility as investors weigh a substantial new share buyback program against recurring anxieties over AI-driven disruption in the creative software sector. While the community remains deeply divided, with many traders monitoring institutional moves from contrarian investors for signs of a bottom, discussions are heavily focused on whether Adobes cash-rich fundamentals and AI-integrated ecosystem can ultimately hold off emerging competitive threats.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing significant volatility driven by conflicting geopolitical headlines surrounding the U.S.-Iran ceasefire and the blockade of the Strait of Hormuz. Market participants are actively debating the credibility of administrative updates as they rotate between aggressive buying on dips and defensive hedging amid concerns over energy prices and broader economic stability.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on high volume as investors react to positive commentary from the CFO regarding production orders and the company's strategic integration into the AI photonics ecosystem. The stock is drawing intense community interest with traders highlighting the company's potential for scaling demand and dismissing a recent short-seller report as a catalyst for a squeeze.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and community buzz following its acquisition of LivePerson, a move that is being framed by bulls as a strategic expansion into voice-messaging integration and enterprise-scale AI. While the acquisition has triggered debate regarding short-term dilution and potential profitability timelines, the community is actively tracking massive volume spikes and short-squeeze potential, with many investors viewing current price dips as accumulation opportunities while anticipating future growth from the combined entity's expanded Fortune 100 client base.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing a sharp surge driven by strong momentum, speculative short-squeeze activity, and heightened retail interest surrounding the company's role in the AI data center power infrastructure. While bulls are excited by the stock's parabolic technical breakout and potential institutional involvement, vocal skeptics remain focused on the firm's persistent negative earnings, high price-to-sales valuation, and significant short interest.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending following a strong quarterly earnings report that featured double-beat results driven by surging da Vinci surgical system placements and high procedure growth. Community members are actively debating the sustainability of the stock's massive after-hours pop, with long-term investors highlighting its durable competitive moat while some traders monitor valuation concerns and high price-to-earnings multiples.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to the upcoming presentation of preclinical data for its CDK9 inhibitor, SLS009, at the AACR conference, alongside persistent community debate over the timeline of its Phase 3 REGAL trial. Investors are actively discussing the potential for a buyout, comparing the company's valuation to recent sector acquisitions, while sentiment remains deeply polarized between those anticipating a major catalyst and those skeptical of trial progress.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies Financial Group Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Jefferies Financial Group reduced their price objective on shares of Clorox from $151.00 to $139.00 and set a "buy" rating for the company in a research note on Tuesday...

Procter & Gamble's EPS Growth Story: Sustainable or Slowing Ahead?

PG leans on pricing power, digital supply chain upgrades and cost discipline to sustain margins, though near-term EPS growth may face pressure.

Clorox (NYSE:CLX) Price Target Cut to $100.00 by Analysts at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reduced their target price on shares of Clorox from $101.00 to $100.00 and set a "hold" rating for the company in a report on Monday...

KBC Group NV Sells 119,357 Shares of The Clorox Company $CLX

KBC Group NV cut its position in The Clorox Company (NYSE:CLX - Free Report) by 71.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,354 shares of the company's stock after selling...

219,206 Shares in The Clorox Company $CLX Acquired by Birch Hill Investment Advisors LLC

Birch Hill Investment Advisors LLC purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the...

$1,000 and a Rocky Market: These 6 Cheap Stocks Are Exactly Where I'd Start

Key PointsEven in uncertain markets, everyday consumer brands like Post Holdings, Hormel Foods, and Clorox benefit from steady demand, making them resilient long-term holds when others panic...

Procter & Gamble Pre-Q3 Earnings: Wise to Buy It Before the Release?

PG heads into Q3 earnings release, with sales and EPS seen rising, but tariffs, commodity costs and a premium valuation could pressure margins.

JPMorgan Chase & Co. Downgrades Clorox (NYSE:CLX) to Underweight

JPMorgan Chase & Co. cut shares of Clorox from a "neutral" rating to an "underweight" rating and set a $99.00 target price on the stock. in a research note on Friday...

Sumitomo Mitsui Trust Group Inc. Sells 17,335 Shares of The Clorox Company $CLX

Sumitomo Mitsui Trust Group Inc. trimmed its stake in The Clorox Company (NYSE:CLX - Free Report) by 5.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 312,055 shares of the company's stock after selling 17,335 s...

Clorox (NYSE:CLX) Price Target Cut to $110.00 by Analysts at Citigroup

Citigroup reduced their target price on Clorox from $115.00 to $110.00 and set a "neutral" rating on the stock in a research report on Wednesday...

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Current Price	$99.61
Prev Close	$102.17
Open	$102.31
Dividend Yield	4.08%
50-Day Moving Average	$112.74
Beta	0.26
Avg. Volume	2.23M
PE Ratio	16.69

52-Week High	$143.96
52-Week Low	$96.66
Market Capitalization	$12.35B
EPS (Annual)	$6.52
Price to Book	-98.81
Revenue Per Employee	$934,736.84

CLX
Clorox Co.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLX News

CLXClorox Co.